Transdel Pharmaceuticals, Inc. (HROW)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

18

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
25-Mar-24 7:00 AM View:	22-Mar-24 Purchase $104.31K	Baum Mark L Chief Executive Officer Director		Transdel Pharmaceuticals, Inc. - HROW	6% 2.02M to 2.14M	0	0	--	--	Show Txns Hide Txns

21-Feb-24 7:29 PM View:	20-Feb-24 Option Exercise $197.18K	Boll Andrew Chief Financial Officer		Transdel Pharmaceuticals, Inc. - HROW	6% 534.17K to 568.09K	0	0	--	--	Show Txns Hide Txns

25-Apr-24 5:19 PM View:	25-Apr-24 Purchase $199.40K	Opaleye Management Inc. 10% Owner		Transdel Pharmaceuticals, Inc. - HROW	5% 3.65M to 3.81M	0	0	--	--	Show Txns Hide Txns

13-Sep-24 5:26 PM View:	11-Sep-24 Payment of Exercise ($1.87M)	Saharek John P. CEO of ImprimisRx		Transdel Pharmaceuticals, Inc. - HROW	29% 232.42K to 299.66K	0	0	--	--	Show Txns Hide Txns